Microsaic Systems plc Integration with SCPA chromatography software
April 26 2017 - 1:01AM
RNS Non-Regulatory
TIDMMSYS
Microsaic Systems plc
26 April 2017
26 April 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Integration with SCPA chromatography software
Microsaic Systems plc (AIM: MSYS), the developer of chip-based
mass spectrometry instruments, is pleased to announce its
collaboration with SCPA GmbH ("SCPA"), and the integration of
Microsaic's 4000 MiD(R) compact mass spectrometer with SCPA's
universal PrepCon 5 preparative data and control software.
The PrepCon 5 software can now be used in conjunction with the
4000 MiD(R) to control all functional aspects of the instrument's
operation, including pumps, motor switch valves, autosamplers,
detectors and fraction racks in any combination. In addition, the
simple user interface allows the current status of the system to be
monitored at any time.
Glenn Tracey, Microsaic's Chief Operating Officer,
commented:
"The flexibility and modular structure of PrepCon 5 allows it to
be adapted to any user's system. This universal capability enhances
the usability of Microsaic's 4000 MiD(R) technology, particularly
with non-specialist users, and appeals to the wider base of
chemists wanting more deterministic approaches to their preparative
work for chemical analyses."
SCPA (Software für Chromatographie und Prozess-Analytik), based
near Bremen, Germany, is a developer of specialist software and
hardware components needed for chromatography applications in
research laboratories.
Enquiries:
Microsaic Systems plc
Jim Ramage, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser
& Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
Citigate Dewe Rogerson
(Financial PR)
Mark Swallow
Marine Perrier +44 (0)20 7638 9571
About Microsaic Systems
Microsaic Systems plc is a high technology company developing
chip-based, bench-top mass spectrometry ("MS") instruments that are
designed to improve the efficiency of Pharma R&D. MS is an
analytical technique of choice for biochemists across many industry
sectors.
Microsaic aims to bring routine MS analysis to the
pharmaceutical scientist, providing powerful methods of analysis to
enable earlier decision making relating to product identification,
purity and bioactivity.
The Company is working with established global companies in
preparative and purification science with expertise in Pharma and
life sciences to co-develop new, integrated and optimised,
application-specific, solutions to improve productivity in the
development of small molecule and novel biologic (peptides,
antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's
smallest MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. The Company is
also developing new MS systems, based on its patented chip
technologies, to address further areas of emerging need in Pharma
R&D.
Microsaic Systems was established in 2001 by a team including
founders from Imperial College London, and was admitted to AIM in
2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAOKPDKABKDDQB
(END) Dow Jones Newswires
April 26, 2017 02:01 ET (06:01 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024